ETIDX
Price
$19.82
Change
+$0.05 (+0.25%)
Updated
Sep 5 closing price
Net Assets
1.22B
FSMDX
Price
$36.90
Change
+$0.34 (+0.93%)
Updated
Sep 4 closing price
Net Assets
44.83B
Interact to see
Advertisement

ETIDX vs FSMDX

Header iconETIDX vs FSMDX Comparison
Open Charts ETIDX vs FSMDXBanner chart's image
Eventide Dividend Growth I
Price$19.82
Change+$0.05 (+0.25%)
VolumeN/A
Net Assets1.22B
Fidelity Mid Cap Index
Price$36.90
Change+$0.34 (+0.93%)
VolumeN/A
Net Assets44.83B
ETIDX vs FSMDX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ETIDX vs. FSMDX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETIDX is a Buy and FSMDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 44.8B vs. ETIDX (1.22B). FSMDX pays higher dividends than ETIDX: FSMDX (1.26) vs ETIDX (0.67). ETIDX was incepted earlier than FSMDX: ETIDX (8 years) vs FSMDX (14 years). ETIDX (0.96) is less costly to investors than FSMDX (0.03). ETIDX is a more actively managed with annual turnover of: 38.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than ETIDX: FSMDX (0) vs ETIDX (100000). FSMDX annual gain was more profitable for investors over the last year : 14.47 vs. ETIDX (8.18). ETIDX return over 5 years is better than : 75.79 vs. FSMDX (71.01).
ETIDXFSMDXETIDX / FSMDX
Total Expense Ratio0.950.033,800%
Annual Report Gross Expense Ratio0.960.033,840%
Fund Existence8 years14 years-
Gain YTD6.4509.77166%
Front LoadN/AN/A-
Min. Initial Investment1000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.22B44.8B3%
Annual Yield % from dividends0.671.2654%
Returns for 1 year8.1814.4757%
Returns for 3 years44.3147.4393%
Returns for 5 years75.7971.01107%
Returns for 10 yearsN/A140.48-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HYPMY4.220.07
+1.57%
Hypera SA
BDRL0.03N/A
N/A
Blonder Tongue Laboratories, Inc.
JWCTF0.66N/A
N/A
JW CAYMAN THERAPEUTICS CO LTD.
AEOXF136.17-1.56
-1.13%
Aeroports de Paris ADP
PGZFF0.09N/A
-5.00%
Pan Global Resource, Inc.